HeartMate 3: Analysis of Outcomes and Future Directions
Study context
- Population
- Patients with advanced heart failure (HF) receiving LVAD support as destination therapy or bridge to heart transplantation
- Comparison
- HeartMate 3 LVAD vs previous similar devices
Methodological detailsSynthesis of 2-year and 5-year HeartMate 3 outcomes from the ELEVATE Registry and MOMENTUM 3 trial
- Synthesis of 2-year and 5-year HeartMate 3 outcomes from the ELEVATE Registry and MOMENTUM 3 trial
Main finding
As reported in the abstract
- HeartMate 3: improved clinical outcomes and lower risk of serious adverse events vs previous similar devices
Original publication
HeartMate 3: Analysis of Outcomes and Future Directions. J Cardiothorac Vasc Anesth. Published 15 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →